Please assess the completion status of the following clinical trial:

Trial Title: Importance of Magnetic Resonance Imaging (MRI) in Treating Breast Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Newly diagnosed breast cancer patients~* Breast cancer patients identified as conservation candidates by their surgeons~Exclusion Criteria:~* Patients with a history of prior breast cancer treatment (recurrence)~* Patients with breast cancer diagnosis during pregnancy (women who could bear children must have a negative pregnancy test before beginning this study)~* Patients with documented sensitivity to gadolinium (contrast agent used during MRI)~* Patients who weigh more than 350 pounds (weight limit on MRI machine)~* Patients who receive neoadjuvant chemotherapy~* Patients with renal insufficiency (serum Cr \> 1.5) due to the danger of nephrogenic systemic sclerosis with the administration of Gadolinium

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 99 Years
- Healthy Volunteers: f

Study Arms:
- MRI (Type: EXPERIMENTAL): Preoperative staging with mammogram, ultrasound, and MRI, followed by surgery (n=200)
- Non-MRI (Type: NO_INTERVENTION): Preoperative staging with mammogram and ultrasound alone, followed by surgery (n=200)

Based on this trial design, predict the completion outcome and termination type (if applicable).